Entyvio ( DrugBank: - )

3 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
94	原発性硬化性胆管炎	11
96	クローン病	73
97	潰瘍性大腸炎	106

94. 原発性硬化性胆管炎

臨床試験数 : 148 / 薬物数 : 118 - (DrugBank : 39) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 141

diseases per page:

Showing 1 to 10 of 11 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2014-003942-28-FR (EUCTR)	04/07/2016	05/07/2016	Efficacy and Safety of Vedolizumab IV in the treatment of PrimarySclerosing Cholangitis in patients ...	Randomized, Global, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy ...	Primary Sclerosing Cholangitis (PSC)Inflammatory Bowel Disease (IBD) MedDRA version: 19.0;Level: LLT ...	Trade Name: Entyvio Product Name: Vedolizumab IV Product Code: MLN0002 INN or Proposed INN: Vedolizumab ...	Takeda Development Centre Europe, Ltd.	NULL	Not Recruiting	Female: yes Male: yes	258	Phase 3	United States;Finland;Spain;Austria;Russian Federation;Israel;United Kingdom;Switzerland;Italy;Franc ...
2	EUCTR2014-003942-28-IT (EUCTR)	20/06/2016	19/01/2021	Efficacy and Safety of Vedolizumab IV in the treatment of Primary Sclerosing Cholangitis in patients ...	Randomized, Global, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy ...	Primary Sclerosing Cholangitis (PSC)Inflammatory Bowel Disease (IBD) MedDRA version: 20.1;Level: LLT ...	Trade Name: Entyvio	TAKEDA DEVELOPMENT CENTRE EUROPE LTD	NULL	Not Recruiting	Female: yes Male: yes	258	Phase 3	United States;Czechia;Finland;Spain;Austria;Israel;Russian Federation;United Kingdom;Switzerland;Ita ...
3	EUCTR2014-003942-28-PL (EUCTR)	15/06/2016	31/05/2016	Efficacy and Safety of Vedolizumab IV in the treatment of PrimarySclerosing Cholangitis in patients ...	Randomized, Global, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy ...	Primary Sclerosing Cholangitis (PSC)Inflammatory Bowel Disease (IBD) MedDRA version: 19.0;Level: LLT ...	Trade Name: Entyvio Product Name: Vedolizumab IV Product Code: MLN0002 INN or Proposed INN: Vedolizumab ...	Takeda Development Centre Europe, Ltd.	NULL	Not Recruiting	Female: yes Male: yes	258	Phase 3	United States;Finland;Spain;Austria;Russian Federation;Israel;Italy;Switzerland;United Kingdom;Franc ...
4	EUCTR2014-003942-28-ES (EUCTR)	29/05/2016	24/02/2016	Efficacy and Safety of Vedolizumab IV in the treatment of PrimarySclerosing Cholangitis in patients ...	Randomized, Global, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy ...	Primary Sclerosing Cholangitis (PSC)Inflammatory Bowel Disease (IBD) MedDRA version: 19.0;Level: LLT ...	Trade Name: Entyvio Product Name: Vedolizumab IV Product Code: MLN0002 INN or Proposed INN: Vedolizumab ...	Takeda Development Centre Europe, Ltd.	NULL	Not Recruiting	Female: yes Male: yes	258	Phase 3	United States;Finland;Spain;Austria;Russian Federation;Israel;Italy;Switzerland;United Kingdom;Franc ...
5	EUCTR2014-003942-28-GB (EUCTR)	26/05/2016	18/03/2016	Efficacy and Safety of Vedolizumab IV in the treatment of PrimarySclerosing Cholangitis in patients ...	Randomized, Global, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy ...	Primary Sclerosing Cholangitis (PSC)Inflammatory Bowel Disease (IBD) MedDRA version: 18.1;Level: LLT ...	Trade Name: Entyvio Product Name: Vedolizumab IV Product Code: MLN0002 INN or Proposed INN: Vedolizumab ...	Takeda Development Centre Europe, Ltd.	NULL	Not Recruiting	Female: yes Male: yes	258	Phase 3	United States;Finland;Spain;Austria;Russian Federation;Israel;Switzerland;United Kingdom;Italy;Franc ...
6	EUCTR2014-003942-28-BE (EUCTR)	13/05/2016	10/03/2016	Efficacy and Safety of Vedolizumab IV in the treatment of PrimarySclerosing Cholangitis in patients ...	Randomized, Global, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy ...	Primary Sclerosing Cholangitis (PSC)Inflammatory Bowel Disease (IBD) MedDRA version: 18.1;Level: LLT ...	Trade Name: Entyvio Product Name: Vedolizumab IV Product Code: MLN0002 INN or Proposed INN: Vedolizumab ...	Takeda Development Centre Europe, Ltd.	NULL	Not Recruiting	Female: yes Male: yes	258	Phase 3	United States;Finland;Spain;Austria;Russian Federation;Israel;Italy;Switzerland;United Kingdom;Franc ...
7	EUCTR2014-003942-28-HU (EUCTR)	09/05/2016	21/03/2016	Efficacy and Safety of Vedolizumab IV in the treatment of PrimarySclerosing Cholangitis in patients ...	Randomized, Global, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy ...	Primary Sclerosing Cholangitis (PSC)Inflammatory Bowel Disease (IBD) MedDRA version: 18.1;Level: LLT ...	Trade Name: Entyvio Product Name: Vedolizumab IV Product Code: MLN0002 INN or Proposed INN: Vedolizumab ...	Takeda Development Centre Europe, Ltd.	NULL	Not Recruiting	Female: yes Male: yes	258	Phase 3	United States;Finland;Spain;Austria;Russian Federation;Israel;Italy;Switzerland;United Kingdom;Franc ...
8	EUCTR2014-003942-28-DE (EUCTR)	09/05/2016	23/03/2016	Efficacy and Safety of Vedolizumab IV in the treatment of PrimarySclerosing Cholangitis in patients ...	Randomized, Global, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy ...	Primary Sclerosing Cholangitis (PSC)Inflammatory Bowel Disease (IBD) MedDRA version: 18.1;Level: LLT ...	Trade Name: Entyvio Product Name: Vedolizumab IV Product Code: MLN0002 INN or Proposed INN: Vedolizumab ...	Takeda Development Centre Europe, Ltd.	NULL	Not Recruiting	Female: yes Male: yes	258	Phase 3	United States;Finland;Spain;Austria;Russian Federation;Israel;Italy;Switzerland;United Kingdom;Franc ...
9	EUCTR2014-003942-28-AT (EUCTR)	13/04/2016	24/03/2016	Efficacy and Safety of Vedolizumab IV in the treatment of PrimarySclerosing Cholangitis in patients ...	Randomized, Global, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy ...	Primary Sclerosing Cholangitis (PSC)Inflammatory Bowel Disease (IBD) MedDRA version: 18.1;Level: LLT ...	Trade Name: Entyvio Product Name: Vedolizumab IV Product Code: MLN0002 INN or Proposed INN: Vedolizumab ...	Takeda Development Centre Europe, Ltd.	NULL	Not Recruiting	Female: yes Male: yes	258	Phase 3	United States;Finland;Spain;Austria;Russian Federation;Israel;Italy;Switzerland;United Kingdom;Franc ...
10	EUCTR2014-003942-28-CZ (EUCTR)	12/04/2016	24/03/2016	Efficacy and Safety of Vedolizumab IV in the treatment of PrimarySclerosing Cholangitis in patients ...	Randomized, Global, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy ...	Primary Sclerosing Cholangitis (PSC)Inflammatory Bowel Disease (IBD) MedDRA version: 19.0;Level: LLT ...	Trade Name: Entyvio Product Name: Vedolizumab IV Product Code: MLN0002 INN or Proposed INN: Vedolizumab ...	Takeda Development Centre Europe, Ltd.	NULL	Not Recruiting	Female: yes Male: yes	258	Phase 3	United States;Finland;Spain;Austria;Russian Federation;Israel;Italy;Switzerland;United Kingdom;Franc ...

First Previous1 2Next Last

先頭へ

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

diseases per page:

Showing 1 to 10 of 73 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-000630-34-GR (EUCTR)	13/01/2023	11/11/2022	A study to evaluate the long term safety of Vedolizumab in Pediatric Patients With Ulcerative Coliti ...	A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Intravenous in Pediatric ...	Active Ulcerative Colitis (UC) or Crohn's disease (CD);Therapeutic area: Diseases [C] - Digestive Sy ...	Trade Name: ENTYVIO Product Name: Vedolizumab INN or Proposed INN: Vedolizumab Other descriptive name: ...	Takeda Development Center Americas, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	93	Phase 3	United States;Czechia;Slovakia;Greece;Spain;Ukraine;Lithuania;Russian Federation;Israel;United Kingd ...
2	EUCTR2021-000630-34-HR (EUCTR)	27/12/2022	05/01/2023	A study to evaluate the long term safety of Vedolizumab in Pediatric Patients With Ulcerative Coliti ...	A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Intravenous in Pediatric ...	Active Ulcerative Colitis (UC) or Crohn's disease (CD);Therapeutic area: Diseases [C] - Digestive Sy ...	Trade Name: ENTYVIO Product Name: Vedolizumab INN or Proposed INN: Vedolizumab Other descriptive name: ...	Takeda Development Center Americas, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	93	Phase 3	United States;Czechia;Slovakia;Greece;Spain;Ukraine;Lithuania;Russian Federation;Israel;United Kingd ...
3	EUCTR2022-000837-17-NL (EUCTR)	07/12/2022	29/09/2022	Lengthening of vedolizumab injections based on drug concentrations in patients with inflammatory bow ...	Subcutaneous vedolizumab drug de-escalation using therapeutic drug monitoring in inflammatory bowel ...	Inflammatory bowel diseases (Crohn's disease, ulcerative colitis);Therapeutic area: Diseases [C] - D ...	Trade Name: Vedolizumab, Entyvio	Amsterdam UMC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 4	Netherlands
4	EUCTR2020-004301-31-IT (EUCTR)	13/10/2021	30/08/2021	A study to evaluate efficacy and safety of Vedolizumab in pediatric subjects with moderately to seve ...	A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intrave ...	Moderately to severely active Crohn's disease (CD) MedDRA version: 20.1;Level: LLT;Classification co ...	Trade Name: ENTYVIO- 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - ...	TAKEDA DEVELOPMENT CENTER AMERICAS INC.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 3	United States;Slovakia;Greece;Spain;Ukraine;Russian Federation;Israel;Italy;France;Australia;China;B ...
5	EUCTR2020-004301-31-SK (EUCTR)	18/09/2021	28/04/2021	A study to evaluate efficacy and safety of Vedolizumab in pediatric subjects with moderately to seve ...	A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intrave ...	Moderately to severely active Crohn’s disease (CD) MedDRA version: 20.1;Level: LLT;Classification co ...	Trade Name: ENTYVIO Product Name: Vedolizumab INN or Proposed INN: Vedolizumab Other descriptive name: ...	Takeda Development Center Americas, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 3	Poland;Belgium;Croatia;Australia;China;Japan;Korea, Republic of;Canada;United States;Czechia;Slovaki ...
6	EUCTR2020-004301-31-HR (EUCTR)	17/08/2021	02/09/2021	A study to evaluate efficacy and safety of Vedolizumab in pediatric subjects with moderately to seve ...	A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intrave ...	Moderately to severely active Crohn’s disease (CD) MedDRA version: 20.1;Level: LLT;Classification co ...	Trade Name: ENTYVIO Product Name: Vedolizumab INN or Proposed INN: Vedolizumab Other descriptive name: ...	Takeda Development Center Americas, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 3	United States;Slovakia;Greece;Spain;Ukraine;Russian Federation;Israel;Italy;France;Australia;China;B ...
7	EUCTR2020-004301-31-HU (EUCTR)	06/08/2021	28/04/2021	A study to evaluate efficacy and safety of Vedolizumab in pediatric subjects with moderately to seve ...	A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intrave ...	Moderately to severely active Crohn’s disease (CD) MedDRA version: 20.1;Level: LLT;Classification co ...	Trade Name: ENTYVIO Product Name: Vedolizumab INN or Proposed INN: Vedolizumab Other descriptive name: ...	Takeda Development Center Americas, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 3	United States;Slovakia;Greece;Spain;Ukraine;Russian Federation;Israel;Italy;France;Australia;China;B ...
8	EUCTR2020-004301-31-LT (EUCTR)	25/06/2021	21/04/2021	A study to evaluate efficacy and safety of Vedolizumab in pediatric subjects with moderately to seve ...	A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intrave ...	Moderately to severely active Crohn’s disease (CD) MedDRA version: 20.1;Level: LLT;Classification co ...	Trade Name: ENTYVIO Product Name: Vedolizumab INN or Proposed INN: Vedolizumab Other descriptive name: ...	Takeda Development Center Americas, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 3	United States;Czechia;Slovakia;Greece;Spain;Ukraine;Lithuania;Russian Federation;Israel;United Kingd ...
9	EUCTR2020-004301-31-ES (EUCTR)	02/06/2021	01/09/2021	A study to evaluate efficacy and safety of Vedolizumab in pediatric subjects with moderately to seve ...	A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intrave ...	Moderately to severely active Crohn’s disease (CD) MedDRA version: 20.1;Level: LLT;Classification co ...	Trade Name: ENTYVIO Product Name: Vedolizumab INN or Proposed INN: Vedolizumab Other descriptive name: ...	Takeda Development Center Americas, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 3	United States;Slovakia;Greece;Spain;Ukraine;Russian Federation;Israel;Italy;France;Australia;China;B ...
10	NCT04002180 (ClinicalTrials.gov)	July 1, 2019	26/6/2019	Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]	Specified Drug-Use Survey on Entyvio for IV Infusion 300 mg [Crohn's Disease]	Crohn's Disease	Drug: Vedolizumab (Genetical Recombination)	Takeda	NULL	Recruiting	N/A	N/A	All	300		Japan

First Previous1 2 3 4 5…8Next Last

先頭へ

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

diseases per page:

Showing 1 to 10 of 106 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05771155 (ClinicalTrials.gov)	May 2023	1/3/2023	Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With ...	A Randomized, Double-blind, Multicenter Phase 3 Study in Patients With Moderately to Severely Active ...	Ulcerative Colitis	Biological: Intravenous (IV) infusions	Polpharma Biologics S.A.	NULL	Not yet recruiting	18 Years	75 Years	All	750	Phase 3	NULL
2	EUCTR2021-000630-34-GR (EUCTR)	13/01/2023	11/11/2022	A study to evaluate the long term safety of Vedolizumab in Pediatric Patients With Ulcerative Coliti ...	A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Intravenous in Pediatric ...	Active Ulcerative Colitis (UC) or Crohn's disease (CD);Therapeutic area: Diseases [C] - Digestive Sy ...	Trade Name: ENTYVIO Product Name: Vedolizumab INN or Proposed INN: Vedolizumab Other descriptive name: ...	Takeda Development Center Americas, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	93	Phase 3	United States;Czechia;Slovakia;Greece;Spain;Ukraine;Lithuania;Russian Federation;Israel;United Kingd ...
3	EUCTR2021-000630-34-HR (EUCTR)	27/12/2022	05/01/2023	A study to evaluate the long term safety of Vedolizumab in Pediatric Patients With Ulcerative Coliti ...	A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Intravenous in Pediatric ...	Active Ulcerative Colitis (UC) or Crohn's disease (CD);Therapeutic area: Diseases [C] - Digestive Sy ...	Trade Name: ENTYVIO Product Name: Vedolizumab INN or Proposed INN: Vedolizumab Other descriptive name: ...	Takeda Development Center Americas, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	93	Phase 3	United States;Czechia;Slovakia;Greece;Spain;Ukraine;Lithuania;Russian Federation;Israel;United Kingd ...
4	EUCTR2022-000837-17-NL (EUCTR)	07/12/2022	29/09/2022	Lengthening of vedolizumab injections based on drug concentrations in patients with inflammatory bow ...	Subcutaneous vedolizumab drug de-escalation using therapeutic drug monitoring in inflammatory bowel ...	Inflammatory bowel diseases (Crohn's disease, ulcerative colitis);Therapeutic area: Diseases [C] - D ...	Trade Name: Vedolizumab, Entyvio	Amsterdam UMC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 4	Netherlands
5	EUCTR2020-004300-34-IT (EUCTR)	13/10/2021	30/08/2021	A study to evaluate efficacy and safety of Vedolizumab in pediatric subjects with moderately to seve ...	A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intrave ...	Moderately to severely active Ulcerative Colitis (UC) MedDRA version: 20.1;Level: LLT;Classification ...	Trade Name: ENTYVIO- 300 MG - POLVERE PE RCONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - ...	TAKEDA DEVELOPMENT CENTER AMERICAS INC.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 3	United States;Slovakia;Greece;Spain;Ukraine;Russian Federation;Israel;Italy;France;Australia;China;B ...
6	EUCTR2019-002485-12-IT (EUCTR)	23/09/2021	22/10/2020	Determination of the Optimal Treatment Target in Ulcerative Colitis	VERDICT: In actiVE ulcerative colitis, a RanDomIzed Controlled Trial for determination of the optima ...	Ulcerative Colitis (UC) MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerativ ...	Trade Name: Entyvio Product Name: Entyvio Product Code: [NA] Other descriptive name: VEDULIZUMAB Trade N ...	ALIMENTIV INC.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	660	Phase 4	United States;France;Belarus;Canada;Poland;Belgium;Ukraine;Russian Federation;Netherlands;United Kin ...
7	EUCTR2020-004300-34-SK (EUCTR)	18/09/2021	28/04/2021	A study to evaluate efficacy and safety of Vedolizumab in pediatric subjects with moderately to seve ...	A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intrave ...	Moderately to severely active Ulcerative Colitis (UC) MedDRA version: 20.1;Level: LLT;Classification ...	Trade Name: ENTYVIO INN or Proposed INN: Vedolizumab Other descriptive name: MLN0002	Takeda Development Center Americas, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 3	United States;Slovakia;Greece;Spain;Ukraine;Russian Federation;Israel;Italy;France;Australia;China;B ...
8	EUCTR2020-004300-34-HR (EUCTR)	18/08/2021	02/09/2021	A study to evaluate efficacy and safety of Vedolizumab in pediatric subjects with moderately to seve ...	A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intrave ...	Moderately to severely active Ulcerative Colitis (UC) MedDRA version: 20.1;Level: LLT;Classification ...	Trade Name: ENTYVIO Product Name: Vedolizumab INN or Proposed INN: Vedolizumab Other descriptive name: ...	Takeda Development Center Americas, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 3	United States;Slovakia;Greece;Spain;Ukraine;Russian Federation;Israel;Italy;France;Australia;China;B ...
9	EUCTR2020-004300-34-HU (EUCTR)	06/08/2021	28/04/2021	A study to evaluate efficacy and safety of Vedolizumab in pediatric subjects with moderately to seve ...	A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intrave ...	Moderately to severely active Ulcerative Colitis (UC) MedDRA version: 20.1;Level: LLT;Classification ...	Trade Name: ENTYVIO Product Name: Vedolizumab INN or Proposed INN: Vedolizumab Other descriptive name: ...	Takeda Development Center Americas, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 3	United States;Slovakia;Greece;Spain;Ukraine;Russian Federation;Israel;Italy;France;Australia;China;B ...
10	EUCTR2020-004300-34-LT (EUCTR)	25/06/2021	21/04/2021	A study to evaluate efficacy and safety of Vedolizumab in pediatric subjects with moderately to seve ...	A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intrave ...	Moderately to severely active Ulcerative Colitis (UC) MedDRA version: 20.1;Level: LLT;Classification ...	Trade Name: ENTYVIO Product Name: Vedolizumab INN or Proposed INN: Vedolizumab Other descriptive name: ...	Takeda Development Center Americas, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	120	Phase 3	United States;Czechia;Slovakia;Greece;Spain;Ukraine;Lithuania;Russian Federation;Israel;United Kingd ...

First Previous1 2 3 4 5…11Next Last

先頭へ